Gene-targeted Therapies for C9orf72 FTD (Investigational)

Type: gene_therapy

Status: Investigational

Developer: Biogen, Ionis Pharmaceuticals

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026